The current mining review study with external consultant could result in a new partner to replace AXIS. This would be like cutting out a cancer if Merlin could break free from AXIS and slowly claw back some of the loan owing.
A lot going on behind the scenes during this suspension period to ensure the company is in a better place on relisting. Timing during wet season wouldn't have been any better to sort out these corporate governance issues.
MED Price at posting:
0.6¢ Sentiment: Buy Disclosure: Held
